$WTW

Analysts’ Opinions Are Mixed on These Financial Stocks: Willis Towers Watson (WTW) and Raymond James Financial (RJF)

Analysts at TD Cowen maintained Buy ratings on Willis Towers Watson (WTW) with a $455 target, and Hold on Raymond James Financial (RJF) with a $161 target. WTW closed at $335.46, near its 52-week high, while RJF closed at $177.93. Analyst consensus for WTW is Moderate Buy with a $374.87 average target, and for RJF is Moderate Buy with a $185.80 average target.

Original reporting
Published Aug 21, 2026, 12:03 PM UTC
Analysis
alphai AI DeskAI-generated
Added to alphai Aug 21, 2026, 5:30 PM UTC. Informational, not investment advice.
How this was made
alphai summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
Analysts’ Opinions Are Mixed on These Financial Stocks: Willis Towers Watson (WTW) and Raymond James Financial (RJF) — source image
Decision brief

The 30-second read

$WTWBullishLow
01

Why it matters

Analyst coverage updates provide fresh guidance but lack a rating change, offering modest trading signals.

02

Market read

Provides new analyst price targets for WTW and RJF, useful for short‑term positioning.

03

What to watch

Broader market momentum and macro data could dominate price action.

Relevance 7/10Novelty 5/10Timing: today

Background

The article aggregates recent analyst ratings and price targets for two financial companies.

Company-level read

Ticker impact

$WTWBullishMedium confidence
Context

TD Cowen analyst maintained a Buy rating and raised the price target to $455, new analyst opinion for the day.

Expected impact

Modest upside of ~10% if market absorbs the higher target.

Evidence & confidence

Analyst upgrade with a higher target can attract buying pressure, but rating unchanged limits impact.

$RJFNeutralMedium confidence
Context

TD Cowen analyst maintained a Hold rating with a $161 price target, new analyst opinion released today.

Expected impact

Limited downside, likely flat to slight dip.

Evidence & confidence

No rating change, but a lower target than current price could temper enthusiasm.

Market effects

Analyst sentiment may influence other financial services stocks.

U.S. financial sector may see modest re‑rating activity.

Limited to investors tracking U.S. financial equities.

Counterpoint

Ratings unchanged suggest limited catalyst; price may remain range‑bound.

Key entities

  • TD Cowen

    Provides research coverage on financial stocks.

Related articles

$WTWMedAI 8/10

WTW (WTW) Q2 2026 Earnings Call Transcript

Willis Towers Watson (WTW) reported Q2 2026 results on an earnings call. Management cited 5% organic revenue growth, adjusted diluted EPS of $3.35 (+17% YoY), and a 19.5% adjusted operating margin (+100 bps). It outlined Propel, targeting $400 million run-rate savings by 2028 and enterprise margin of about 30%, plus $450 million Q2 buybacks.

$WTWMedAI 8/10

WTW (WTW) Q2 2026 Earnings Call Transcript

Willis Towers Watson (WTW) reported Q2 2026 results on its earnings call. Management cited 5% organic revenue growth, adjusted diluted EPS of $3.35 (+17% YoY), and a 19.5% adjusted operating margin (+100 bps). The company targets $400m run-rate savings by 2028 from a ~$625m AI investment and $360m free cash flow in the first half of 2026.

$WTWMed

Why is Willis Towers Watson stock climbing today?

Willis Towers Watson (WTW) shares rose about 1.5% after Q2 results beat expectations and prompted analyst target increases. According to the company, adjusted EPS was $3.35 vs $3.13 consensus, revenue about $2.47B vs $2.41B, with 5% organic growth. Goldman raised its target to $385 and UBS to $405 (both Buy), while Citigroup downgraded to Neutral with a $345 target.

$WTWMedAI 8/10

WTW (WTW) Q2 2026 Earnings Call Transcript

Thursday, July 30, 2026 at 9:00 a.m. ET CALL PARTICIPANTS Chief Executive Officer - Carl A. Hess Chief Financial Officer - Andrew Krasner President of Health, Wealth & Career - Julie Gebauer President of Risk & Broking - Lucy Clarke TAKEAWAYS Organic Revenue Growth -- 5%, reflecting strength in the Risk & Broking segment and steady performance in Health, Wealth & Career.